PMID: 137 BentezSCorderoASantamaraPGRedondo-PedrazaJRochaASCollado-SolAet al
People with diabetes taking tirzepatide were 65% less likely to be diagnosed with depression and 60% less likely to have anxiety, compared to people not taking GLP-1 drugs
Retatrutide is a synthetic peptide investigated as a simultaneous agonist of the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors
These may indicate inner ear pathology, stroke, or other medical emergencies unrelated to semaglutide
However, tirzepatide may be prescribed for weight loss under the brand name Zepbound
If you need extra support for your skin concerns in an integrative approach, get in touch by emailing [email protected]